JM4 Inhibitors
Chemical inhibitors of JM4 function by disrupting the cellular signaling pathways and processes that are essential for its activity. Alsterpaullone and Roscovitine, for example, are inhibitors of cyclin-dependent kinases (CDKs). CDKs play a crucial role in the regulation of the cell cycle, which is intimately connected to protein trafficking and folding mechanisms. By inhibiting CDKs, these chemicals can create a cellular environment that indirectly leads to the functional inhibition of JM4. The result is a disturbance in the normal operation of cellular processes that JM4 is involved in, such as the trafficking and proper folding of proteins, which are critical for its function.
Furthermore, Sotrastaurin, Go6983, Bisindolylmaleimide I, Chelerythrine, Ruboxistaurin, Midostaurin, Ro-31-8220, Enzastaurin, Staurosporine, and K252a target protein kinase C (PKC) or a range of protein kinases in the case of the more broad-spectrum inhibitors like Staurosporine and K252a. These kinases are involved in a variety of signaling pathways that regulate JM4 function. Inhibition of PKC, for instance, can lead to altered cellular signaling events, disrupting the processes that facilitate JM4's role within the cell. The chemicals that selectively inhibit PKC, such as Ruboxistaurin and Enzastaurin, specifically dampen the signaling pathways that are crucial for JM4 activity. Staurosporine and K252a, while less selective, inhibit a wide range of kinases, which can also result in the functional inhibition of JM4 by generally disrupting kinase-dependent signaling networks.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is a known inhibitor of cyclin-dependent kinases (CDKs). JM4, while not directly inhibited by CDK inhibitors, can be functionally inhibited due to the role of CDKs in cell cycle regulation and subsequent protein trafficking and folding processes in which JM4 is involved. Suppression of CDK activity can lead to an environment where JM4 function is compromised. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine serves as a CDK inhibitor, similar to Alsterpaullone. By inhibiting CDKs, Roscovitine can disrupt the cell cycle and indirectly affect the cellular processes, including those related to protein trafficking, where JM4 is known to play a role. This disruption can result in the functional inhibition of JM4. | ||||||
Sotrastaurin | 425637-18-9 | sc-474229 sc-474229A | 5 mg 10 mg | $300.00 $540.00 | ||
Sotrastaurin is a protein kinase C (PKC) inhibitor. PKC is involved in various signaling pathways that can regulate the function of JM4. By inhibiting PKC, Sotrastaurin can alter signaling events that are essential for JM4’s activity, leading to its functional inhibition. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is another PKC inhibitor. Inhibiting PKC can lead to functional inhibition of JM4 by altering the signaling pathways in which PKC and JM4 are involved, thereby affecting JM4's role in cellular processes. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective inhibitor of PKC. Through the inhibition of PKC, it can modulate signaling pathways and influence cellular functions where JM4 is active, leading to the functional inhibition of JM4. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine is a potent inhibitor of PKC. By inhibiting PKC, Chelerythrine can disrupt signaling pathways where JM4 operates, leading to the functional inhibition of JM4. | ||||||
Ruboxistaurin | 169939-94-0 | sc-507364 | 25 mg | $1080.00 | ||
Ruboxistaurin is a selective inhibitor of PKCβ. Although PKCβ is not the direct target of JM4, the inhibition of this kinase can disrupt related signaling pathways and thus functionally inhibit JM4. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
Ro-31-8220 is a PKC inhibitor that can disrupt the kinase activity necessary for the proper functioning of JM4, leading to its functional inhibition. | ||||||
Enzastaurin | 170364-57-5 | sc-364488 sc-364488A sc-364488B | 10 mg 50 mg 200 mg | $259.00 $612.00 $1721.00 | 3 | |
Enzastaurin is a PKCβ inhibitor. By specifically inhibiting PKCβ, it can impede the signaling pathways and cellular processes that JM4 is involved in, thereby functionally inhibiting JM4. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of many protein kinases. Even though it is not specific to JM4, its broad kinase inhibition can disrupt the signaling networks crucial for JM4 function, leading to its functional inhibition. | ||||||